IPO GMP: what the grey market premium hides

Every time a hot IPO opens, the same ritual plays out: people open a tracker, glance at a single figure — the GMP — and let it decide whether they apply. With a wave of issues listing this season, that number is being refreshed obsessively. It feels like an early look at listing day. It's really something looser and more dangerous than that, and the gap between what people think GMP means and what it actually is has quietly cost a lot of retail investors money.

What the grey market premium actually is

GMP — grey market premium — is the extra amount buyers in an unofficial, off-exchange market are willing to pay for IPO shares (or the right to them) before they list. If an IPO is priced at a certain band and the grey market is trading it at a premium, that premium is the GMP. Crucially, it is not an official price, not regulated, not reported by the exchange, and set by a small, opaque group of dealers. It is a rumour with a number attached — an informal sentiment reading, not a valuation.

What it can tell you — and what it absolutely can't

Used honestly, GMP is a rough gauge of demand and hype in the days before listing — whether the crowd is excited or cold. What it cannot tell you is what the business is worth, whether the price band is fair, or what the stock will do a week, month or year after listing. It predicts, at best, the mood of the first few minutes of trading — and even that only until it doesn't. A high GMP is a measure of how loud the room is, not how good the company is.

Why chasing GMP gets people burned

The grey market is thin and easy to nudge, so the number can be inflated to manufacture FOMO and then evaporate before listing. GMP swings violently in the final days, and a figure that looked juicy on Tuesday can collapse by Thursday's open. Because it says nothing about fundamentals, people who apply purely on a fat GMP end up holding overpriced shares once the hype clears — the listing 'pop' they were promised either never comes or reverses within hours. The number that pulled them in had no idea what the company was worth, and neither, by then, did they.

How to actually use GMP (as one input, not the decision)

Treat GMP the way you'd treat a crowd's cheer — informative about excitement, useless as a verdict. Read it alongside the things that actually matter: the company's financials and growth, how richly the IPO is priced versus listed peers, the reason it's raising money, promoter and anchor-investor quality, and overall subscription across investor categories. If the fundamentals are sound, a positive GMP is a small extra tailwind. If they're weak, no GMP is worth chasing. And decide your exit before you apply — whether you're in for a listing-day flip or for the long term changes everything about how much a fickle premium should sway you.

The steps to actually apply — UPI/ASBA, cut-off price, lot size — are a separate thing worth getting right so you don't fumble a good decision at checkout.